Previous Close | 20.70 |
Open | 24.50 |
Bid | 22.30 |
Ask | 23.20 |
Strike | 210.00 |
Expire Date | 2024-10-18 |
Day's Range | 24.50 - 24.50 |
Contract Range | N/A |
Volume | |
Open Interest | 129 |
Hologic's (HOLX) GYN Surgical Q2 performance was driven by strong results from MyoSure and Fluent Fluid Management.
Lantheus' (LNTH) robust revenues from the majority of its segments drive its first-quarter performance.
Bruker's (BRKR) BioSpin segment witnessed growth across biopharma, academic government and industrial research in the first quarter of 2024.